Rethinking ADHD: More Than a Deficit

If you have spent any time researching ADHD, you have probably noticed something strange: the name itself does not match the experience. Attention Deficit Hyperactivity Disorder suggests a shortage of attention and an excess of movement. But anyone who has ever lost four hours to a fascinating project while forgetting to eat lunch knows that ADHD is not really about a deficit of attention. It is about the regulation of attention.

This distinction matters more than it might seem. When we define a condition primarily by what appears broken from the outside, we miss the richer, more accurate picture of what is actually happening inside. And we risk reducing complex human beings to a checklist of deficits.

As a psychiatrist who works with adults and adolescents navigating ADHD, I want to start this series by doing something that may feel unusual: stepping back from the diagnostic criteria for a moment and asking a more fundamental question. What is ADHD, really? Not just as a clinical label, but as a way of experiencing the world?

The Problem with the Name

The term “Attention Deficit Hyperactivity Disorder” was formalized in 1987, and it has been a source of confusion ever since. The name implies two things: that people with ADHD cannot pay attention, and that they are physically hyperactive. Both of these are, at best, incomplete descriptions [1].

People with ADHD can pay attention. In many cases, they can pay extraordinary attention, sometimes to the point of losing track of time, meals, and the world around them. This capacity for deep, immersive focus, often called hyperfocus, is not a contradiction of the diagnosis. It is a core feature of how the ADHD brain allocates attention [2].

The real issue is not the amount of attention available but the brain’s ability to direct it consistently toward things that are important but not inherently interesting. Dr. William Dodson, a psychiatrist who has specialized in ADHD for decades, describes this as an “interest-based nervous system” rather than a “priority-based” one [3]. In a neurotypical brain, the executive function system can override personal interest in favor of deadlines, responsibilities, and long-term goals. In the ADHD brain, this override system is less reliable. Attention flows toward novelty, urgency, challenge, and passion, and it resists being manually directed toward tasks that lack those qualities.

The hyperactivity component is similarly misunderstood. While some children with ADHD are visibly restless, many, particularly girls and the predominantly inattentive subtype, are not hyperactive at all in the physical sense [4]. In adults, hyperactivity often transforms into internal restlessness: a mind that will not quiet down, a compulsive need for stimulation, difficulty sitting through meetings or relaxing without a screen. The DSM-5 acknowledged this shift when it updated its criteria to include adult-specific examples [5], but the name still carries the implication of a fidgety child who cannot sit still, which is only one face of a much more varied condition.

A Different Brain, Not a Broken One

Neuroscience has made significant progress in understanding what is happening in the ADHD brain, and the picture it paints is one of difference, not damage. The core neurobiological findings center on two neurotransmitter systems, dopamine and norepinephrine, and the brain networks they support [6, 7].

Dopamine plays a critical role in motivation, reward processing, and the ability to sustain effort toward goals that do not offer immediate payoff. Norepinephrine supports alertness, focus, and the capacity to filter relevant information from noise. In the ADHD brain, signaling in both of these systems, particularly in the prefrontal cortex, operates differently than in neurotypical brains [6, 8]. The prefrontal cortex is the brain’s executive control center, responsible for planning, prioritizing, impulse control, and working memory. When dopamine and norepinephrine activity in this region is suboptimal, the result is not a broken brain but a brain whose regulatory dial is calibrated differently.

This is why people with ADHD can be brilliant problem-solvers in a crisis (when adrenaline and urgency provide the neurochemical boost their prefrontal cortex needs) while struggling to start a report that is due next week (when no such boost is available). It is not a character flaw. It is neurochemistry.

Brain imaging studies have also revealed differences in how networks communicate with each other. The default mode network, which is active during rest and mind-wandering, and the task-positive network, which engages during focused work, typically operate in a seesaw pattern: when one is active, the other quiets down. In the ADHD brain, this seesaw is less reliable. The default mode network may intrude during tasks that require sustained focus, leading to the experience of “zoning out” or having thoughts wander unbidden during a conversation [9]. This is not laziness or disinterest. It is a brain network coordination issue that the person often has limited voluntary control over.

Reframing ADHD: The VAST Perspective

In their book ADHD 2.0, psychiatrists Edward Hallowell and John Ratey propose a reframing of ADHD that many patients find immediately resonating. They suggest the term VAST: Variable Attention Stimulus Trait [10]. This is not an official diagnostic term, and it has not been adopted by the DSM or the research community as a formal category. But as a clinical lens, a way of helping patients understand their own experience, I find it remarkably useful.

VAST captures several truths that the traditional name obscures. First, “variable” acknowledges that attention in ADHD is not consistently absent but fluctuating: sometimes too scattered, sometimes too locked in, rarely in the comfortable middle. Second, “stimulus” reflects the brain’s relationship with stimulation, its hunger for it, its difficulty functioning without enough of it, and its tendency to seek it in ways that can be both productive (diving deep into a creative project) and counterproductive (compulsive phone scrolling). Third, “trait” positions ADHD as a dimension of human neurology rather than purely a disease, which is more consistent with what genetics and neuroscience are showing us [10].

I want to be transparent about an important nuance here. Reframing ADHD as a trait or a difference rather than purely a disorder is valuable for reducing stigma and helping people understand their brains. But it can also risk minimizing the very real impairment that ADHD causes. The lost jobs, the failed relationships, the chronic sense of underperformance, the emotional toll of knowing you are capable of more than your executive function will allow: these are not trivial, and they deserve clinical attention. The goal of reframing is not to pretend ADHD does not cause suffering. It is to recognize that the suffering comes from the mismatch between how the brain works and what the environment demands, not from something fundamentally wrong with the person [11].

ADHD and Creativity: What the Research Shows

One of the most commonly discussed “superpowers” of ADHD is creativity. Is this backed by evidence, or is it wishful thinking? The answer, as with most things in ADHD, is nuanced.

A comprehensive review of 31 behavioral studies found that people with high ADHD trait scores consistently demonstrated enhanced divergent thinking, the ability to generate multiple original ideas from a single starting point [12]. This finding held across both subclinical populations (people with ADHD traits who do not meet full diagnostic criteria) and clinically diagnosed groups, who showed high rates of creative achievements and abilities. The review also noted that ADHD traits were particularly associated with originality and the ability to overcome the constraining effects of prior knowledge, essentially, thinking outside the box not as a cliché but as a measurable cognitive tendency [12, 13].

More recent research has connected this to mind-wandering patterns. A 2025 study presented at the World Congress on ADHD found that deliberate mind-wandering (the kind that leads to creative breakthroughs) was positively associated with both ADHD symptoms and divergent thinking, while spontaneous, uncontrolled mind-wandering was more associated with functional impairment [14]. This suggests that the same neural tendency, a default mode network that does not fully disengage, can be either a creative asset or a functional liability depending on context and the individual’s ability to harness it.

A 2024 study of neurodivergent students found that those with ADHD outperformed neurotypical peers specifically on verbal originality, further supporting the divergent thinking advantage [15]. However, convergent thinking, the ability to arrive at a single correct answer, does not appear to be enhanced in ADHD [12].

So the honest answer is this: ADHD is associated with genuine creative strengths, particularly in generating novel ideas and overcoming conventional thinking patterns. But creativity alone does not pay the bills if executive function barriers prevent follow-through. Part of effective ADHD treatment is building the scaffolding that allows these creative strengths to actually produce results in the real world.

Beyond Neurotransmitters: What Integrative Psychiatry Adds

The standard understanding of ADHD focuses heavily on dopamine and norepinephrine, and for good reason: these neurotransmitter systems are central to the condition and to the mechanism of action of ADHD medications. But in my practice, I have found that this focus, while necessary, is often incomplete.

The brain does not operate in isolation from the body. Neurotransmitter production depends on adequate levels of specific nutrients, including iron, zinc, magnesium, B vitamins, and omega-3 fatty acids [16]. Brain function is shaped by blood sugar stability, gut health, inflammatory status, and hormonal balance. When these systems are out of balance, ADHD symptoms can worsen regardless of whether someone is taking medication, and correcting these imbalances can sometimes produce meaningful improvement.

This is not alternative medicine or a rejection of conventional psychiatry. It is an acknowledgment that the brain is a biological organ embedded in a body, and that treating it as if it exists in a vacuum, responding only to neurotransmitter-targeted medication, is an incomplete approach. In the posts that follow in this series, we will explore each of these dimensions in depth: from the gut-brain connection and blood sugar to hormones and nutritional status. But the foundation is this: ADHD is real, it has biological roots, and those roots extend further into the body than most psychiatric evaluations explore.

What This Means for You

If you are reading this because you suspect you might have ADHD, or because you have been recently diagnosed and are trying to make sense of it, I want you to take away a few things from this first post.

Your brain is not broken. It is wired differently in ways that create genuine challenges in a world designed for neurotypical executive function, and it may also carry genuine strengths that have been underrecognized or underutilized. Both of these things can be true simultaneously.

The name “ADHD” is misleading, and if it has made you doubt your diagnosis because you do not feel like you have a “deficit” of attention, you are not alone. What you likely have is a brain that regulates attention, motivation, and emotional response in ways that do not fit neatly into the demands of modern life.

Understanding ADHD at a neurobiological level, not just as a checklist of symptoms, is the first step toward treatment that actually works. And treatment that works often means going beyond medication alone to examine the metabolic, nutritional, hormonal, and lifestyle factors that shape how your brain functions day to day.

In the next post in this series, How ADHD Is Actually Diagnosed: Beyond the Checklist, we will look at what a thorough ADHD evaluation actually involves, why online quizzes are not enough, and what to expect from a comprehensive assessment.

* * *

Frequently Asked Questions

Q: Is ADHD a real medical condition or just a personality trait?

A: ADHD is a well-established neurodevelopmental condition with decades of research supporting its biological basis. Brain imaging studies show consistent differences in prefrontal cortex function and neurotransmitter signaling. At the same time, ADHD exists on a spectrum, and some researchers argue it is best understood as an extreme of normal human variation in attention and self-regulation. Both perspectives can coexist: ADHD is biologically real and can cause genuine impairment, while also representing a natural form of neurological diversity.

Q: What does ADHD actually feel like in adults?

A: In adults, ADHD often presents as chronic difficulty with organization, time management, and follow-through, even when the person is intelligent and motivated. Many adults describe internal restlessness rather than physical hyperactivity, along with difficulty prioritizing tasks, a tendency to start many projects without finishing them, sensitivity to boredom, and emotional reactions that feel disproportionate to the situation. Many adults also describe a painful gap between what they know they are capable of and what they actually accomplish day to day.

Q: Can you have ADHD and still be successful?

A: Absolutely. Many adults with ADHD develop compensatory strategies, often at significant personal cost, that allow them to succeed in school and at work. High intelligence, supportive environments, and strong interest in one’s work can all mask ADHD for years. In fact, many adults are not diagnosed until a life transition (a more demanding job, becoming a parent, perimenopause) overwhelms their existing coping strategies. Success does not rule out ADHD, and delayed diagnosis is common, especially in women and high achievers.

Q: Is the VAST (Variable Attention Stimulus Trait) model scientifically validated?

A: VAST is a clinical reframing proposed by Drs. Hallowell and Ratey in their book ADHD 2.0, not a formal diagnostic category recognized by the DSM-5 or the broader research community. It is not “scientifically validated” in the way that DSM criteria have been tested through large-scale studies. However, many of the ideas underlying VAST, including the variable nature of attention in ADHD, the role of stimulation-seeking, and the spectrum nature of the condition, are well supported by neuroscience research. It is best understood as a helpful framework for patients rather than a replacement for clinical diagnostic criteria.

Q: What is integrative psychiatry, and how does it approach ADHD differently?

A: Integrative psychiatry combines conventional psychiatric evaluation and treatment (including medication when appropriate) with a broader investigation of the biological factors that influence brain function. For ADHD, this means assessing not only symptoms and neurotransmitter function but also nutritional status, metabolic health, gut health, hormonal balance, inflammatory markers, and environmental exposures. The goal is to identify and address root causes that may be contributing to or worsening symptoms, leading to treatment plans that are more personalized and comprehensive than medication alone.

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing; 2022.
2. Ashinoff BK, Abu-Akel A. Hyperfocus: the forgotten frontier of attention. Psychological Research. 2021;85(1):1-19. doi:10.1007/s00426-019-01245-8
3. Dodson WM. Emotional regulation and rejection sensitivity in ADHD. ADDitude Magazine Expert Webinar Series. 2020.
4. Cortese S, Bellgrove MA, Brikell I, et al. Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies. World Psychiatry. 2025;24(3):347-371. doi:10.1002/wps.21374
5. Wolraich ML, Hagan JF, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528
6. Arnsten AFT. The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex. Journal of Pediatrics. 2009;154(5):I-S43. doi:10.1016/j.jpeds.2009.01.018
7. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological Psychiatry. 2011;69(12):e145-e157. doi:10.1016/j.biopsych.2011.02.036
8. MacDonald HJ, Kleppe R, Szigetvari PD, Haavik J. The dopamine hypothesis for ADHD: an evaluation of evidence accumulated from human studies and animal models. Frontiers in Psychiatry. 2024;15:1492126. doi:10.3389/fpsyt.2024.1492126
9. Parlatini V, Itahashi T, Lee Y, et al. From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD. Neuroscience and Biobehavioral Reviews. 2024;164:105841. doi:10.1016/j.neubiorev.2024.105841
10. Hallowell EM, Ratey JJ. ADHD 2.0: New Science and Essential Strategies for Thriving with Distraction, from Childhood Through Adulthood. Ballantine Books; 2021.
11. Faraone SV, Bellgrove MA, Brikell I, et al. Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers. 2024;10:11. doi:10.1038/s41572-024-00495-0
12. Hoogman M, Stolte M, Baas M, Kroesbergen E. Creativity and ADHD: a review of behavioral studies, the effect of psychostimulants and neural underpinnings. Neuroscience and Biobehavioral Reviews. 2020;119:66-85. doi:10.1016/j.neubiorev.2020.09.029
13. White HA, Shah P. Scope of semantic activation and innovative thinking in college students with ADHD. Creativity Research Journal. 2016;28(3):275-282. doi:10.1080/10400419.2016.1195655
14. Fang H, et al. Mind wandering connects ADHD symptoms to creativity and functional impairment. Presented at: World Congress on ADHD; 2025; Radboud University Medical Centre, Netherlands.
15. Pasarín-Lavín T, García T, Abín A, Rodríguez C. Neurodivergent students: a continuum of skills with an emphasis on creativity and executive functions. Applied Neuropsychology: Child. 2024;1-13. doi:10.1080/21622965.2024.2406914
16. Robberecht H, Verlaet AAJ, Breynaert A, De Bruyne T, Hermans N. Magnesium, iron and zinc supplementation for the treatment of attention deficit hyperactivity disorder: a systematic review on the recent literature. Current Medicinal Chemistry. 2020;27(26):4416-4430. doi:10.2174/0929867325666180904143020